I have an appointment with an Orthopedist for assessment at the end of the month
There is no published, peer-reviewed human clinical trial of subcutaneous or systemic GHK-Cu demonstrating efficacy for any outcome
They provide a natural and effective way to support skin health and lightening
The Shared Foundation: GHK-Cu + BPC-157 + TB-500 Both GLOW and KLOW are built on the same three-peptide base a combination that pairs the leading compounds from skin/anti-aging research and recovery research: This three-way base is studied for combining the major tissue-repair mechanisms gene expression (GHK-Cu), angiogenesis (BPC-157), and cell migration (TB-500) in a single formulation
Pareek, V., Tian, H., Winograd, N
Side effects are mild and short-lived, such as temporary bruising at the insertion site or a warm sensation during the infusion